Janux Therapeutics Inc
NASDAQ:JANX 4:00:00 PM EDT
| Market Cap (Intraday) | 2.71B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $47.01 |
| 50-Day MA | $44.47 |
| 200-Day MA | $37.76 |
Janux Therapeutics Inc Stock, NASDAQ:JANX
10955 Vista Sorrento Parkway, Suite 200, San Diego, California 92130
United States of America
Phone: +1.858.751.4493
Number of Employees: 64
Description
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.